Influence of matrix metalloproteinase 9 (MMP-9) on the metastatic behavior of oropharyngeal cancer

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4129-4134

  Dunne A A ^a   Grobe A ^a   Sesterhenn, A M ^a   Barth, P ^a   Dalchow, C ^a   Werner, J A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Matrix metalloproteinases; Oropharynx; Prognostic markers; Squamous cell carcinoma

Indexed keywords

GELATINASE B;

ADULT; AGED; ARTICLE; CANCER STAGING; CORRELATION ANALYSIS; ENZYME ANALYSIS; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OROPHARYNX CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS;

EID: 27944498141     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 9: 541-573, 1993.
2. MacDougall JR and Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Met Rev 14: 351-362, 1995.
3. Denis F, Garaud P, Manceau A et al: Prognostic value of the number of involved nodes after neck dissection in oropharyngeal and oral cavity carcinoma. Cancer Radiother 5: 12-22, 2001.
4. Tankere F, Camproux A, Barry B, Guedon C, Depondt J and Gehanno P: Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope 110: 2061-2065, 2000.
5. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biological activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000.
6. Kossakowska AE, Hutchcroft SA, Urbanski SJ and Edwards DR: Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 3: 1401-1408, 1996.
7. Himelstein BP, Canete-Soler R, Bernhard EJ and Muschel RJ: Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci 107: 477-486, 1994.
8. Pickett KL, Harber GJ, DeCarlo AA et al: 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro. J Dent Res 78: 1354-1361, 1999.
9. Herbst RS, Yano S, Kuniyasu H et al: Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 6: 790-797, 2000.
10. Wood M, Fudge K, Mohler JL et al: In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis 15: 246-258, 1997.
11. Garbett EA, Reed MW and Brown NJ: Proteolysis in human breast and colorectal cancer. Br J Cancer 81: 287-293, 1999.
12. Kanayama H: Matrix metalloproteinases and bladder cancer. J Med Invest 48: 31-43, 2001.
13. Kawata R, Shimada T, Maruyama S, Hisa Y, Takenaka H and Murakami Y: Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis. Acta Otolaryngol 122: 101-106, 2002.
14. Liotta L, Kleinermann J and Saidel G: Quantitative relationship of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 34: 997-1004, 1974.
15. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
16. Risau W: Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
17. Riedel F, Götte K, Bergler W and Hörmann K: Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol Rep 8: 471-476, 2001.
18. Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M and Shiba M: Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients. Clin Cancer Res 5: 149-153, 1998.
19. Riedel F, Götte K, Schwalb J, Bergler W and Hörmann K: Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 17: 1099-1105, 2000.
20. Woolgar JA: Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg 37: 181-186, 1999.
21. Murray D, Morrin M and McDonell S: Increased invasion and expression MMP-9 in human colorectal cell lines by a CD44-dependent mechanism. Anticancer Res 24(2A): 489-494, 2004.
22. Liotta LA, Rao CN and Wewer UM: Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55: 1037-1057, 1986.
23. Yagel S, Khokha R, Denhardt DT, Kerbel RS, Parhar RS and Lala PK: Mechanisms of cellular invasiveness: a comparison of amnion invasion in vitro and metastatic behavior in vivo. J Natl Cancer Inst 81: 768-775, 1989.
24. Stahle-Bäckdahl M and Parks WC: 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol 142: 995-1000, 1993.
25. Miyajima Y, Nakano R and Morimatsu M: Analysis of expression of matrix metalloproteinase-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 104: 678-684, 1995.
26. Nielsen BS, Timshel S, Kjeldsen L et al: 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer 65: 57-62, 1996.
27. Sugiura Y, Shimada H, Seeger RC, Laug WE and DeClerck YA: Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 58: 2209-2216, 1998.
28. Kurahara S, Shinohara M, Ikebe T et al: Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21: 627-638, 1999.
29. Chen W, Abnet CC, Wei WQ, Roth MJ, Lu N, Taylor PR, Pan QJ, Luo XM, Dawsey SM and Qiao YL: Serum markers as predictors of esophageal squamous dysplasia and early cancer. Anticancer Res 24(5B): 3245-3249, 2004.
30. Ikebe T, Shinohara M, Takeuchi H et al: Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17: 315-323, 1999.
31. O-charoenrat P, Rhys-Evans PH and Eccles SA: Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813-820, 2001.
32. Hong SD, Hong SP, Lee JI and Lim CY: Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 36: 207-213, 2000.